Uckelmann, H., S. M. Kim et al. (2020, January) “Therapeutic targeting of preleukemia cells in a mouse model of NPM1 mutant acute myeloid leukemia.” Science. 367(6477):586-590.
Access Scientific References for Our Pipeline Below
-
Revumenib / Menin-MLLr inhibitors
-
Axatilimab / Targeting CSF-1R
Radojcic, V., et al.(2023, May) “Safety, Tolerability, and Efficacy of Axatilimab, a Colony-Stimulating Factor 1 Receptor (CSF-1R) Humanized Antibody, in Advanced Chronic Graft-versus-host Disease–Related Bronchiolitis Obliterans Syndrome.” Slides and poster presented at the American Thoracic Society 2023, Washington, DC
-
Entinostat / Immunomodulation
Gandhi L.., M. Johnson, et al. (2017, November). “ENCORE-601: Phase 1b/2 study of entinostat (ENT) in combination with pembrolizumab (PEMBRO) in patients with non-small cell lung cancer.” Poster and slides presented at the Society for the Immunotherapy of Cancer Annual Meeting, National Harbor, MD.
-
Entinostat / Breast Cancer